Proceedings of the Association for Research in Vision and Ophthalmology and Champalimaud Foundation Ocular Oncogenesis and Oncology Conference

• Type of Material: Article
• Authors: Justin R. Smith, Flinders University South Australia; Jacob Pe'er, Hadassah Hebrew University; Rubens N. Belfort, Federal University of Sao Paulo; Fatima Cardoso, Champalimaud Centre for the Unknown; Richard D. Carvajal, Columbia University; Carlos Carvalho, Champalimaud Centre for the Unknown; Sarah E. Coupland, University of Liverpool; Laurence Desjardins, Institut Curie; Jasmine H. Francis, Memorial Sloan Kettering Cancer Center; Brenda L. Gallie, SickKids Hospital; Dan S. Gombos, University of Texas MD Anderson Cancer Center; Hans Grossniklaus, Emory University; Steffen Heegaard, Rigshospitalet; Martine J. Jager, Leiden University; Swathi Kaliki, L.V. Prasad Eye Institute; Bruce R. Ksander, Harvard Medical School; Markus Maeurer, Champalimaud Centre for the Unknown; Eduardo Moreno, Champalimaud Centre for the Unknown; Jose S. Pulido, Mayo Clinic; Bettina Ryll, Melanoma Patient Network Europe; Arun D. Singh, Cleveland Clinic; Junyang Zhao, Beijing Childrens Hospital; Antonio Parreira, Champalimaud Centre for the Unknown; David J. Wilson, Oregon Health & Science University; Joan M. O'Brien, University of Pennsylvania
• Language: English
• Date: 2019-01-01
• Publisher: Association for Research in Vision and Ophthalmology (ARVO)
• Publication Version: Final Published Version
• Copyright Statement: 2019 The Authors
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1167/tvst.8.1.9
• Title of Journal or Parent Work: Translational Vision Science & Technology
• ISSN: 2164-2591
• Volume: 8
• Issue: 1
• Start Page: 9
• End Page: 9
• Grant/Funding Information: This work was supported in part by Australian Research Council (Future Fellowship 130101648 to JRS).
• Keywords: MODEL; eye; VITREORETINAL LYMPHOMA; CANCER; UVEAL MELANOMA; oncogenesis; REVEALS; GUIDELINES; MANAGEMENT; Ophthalmology; oncology; Science & Technology; CELL; Life Sciences & Biomedicine; DIAGNOSIS; SURVIVAL; ocular
• Research Categories: Health Sciences, Oncology; Health Sciences, Opthamology; Health Sciences, Pathology

Abstract

The 2018 Ocular Oncogenesis and Oncology Conference was held through a partnership of the Association for Research in Vision and Ophthalmology (ARVO) and the Champalimaud Foundation. Twenty-one experts from international ocular oncology centers, from the Champalimaud Clinical Centre and the Champalimaud Foundation Cancer Research Program, and from patient advocacy organizations, delivered lectures on subjects that ranged from global ocular oncology, to basic research in mechanisms of ocular malignancy, to clinical research in ocular cancers, and to anticipated future developments in the area. The scientific program of the conference covered a broad range of ocular tumors-including uveal melanoma, retinoblastoma, ocular surface tumors, and adnexal and intraocular lymphomas-and pathogenesis and management were deliberated in the context of the broader systemic cancer discipline. In considering the latest basic and clinical research developments in ocular oncogenesis and oncology, and providing the opportunity for cross-talk between ocular cancer biologists, systemic cancer biologists, ocular oncologists, systemic oncologists, patients, and patient advocates, the forum generated new knowledge and novel insights for the field. This report summarizes the content of the invited talks at the 2018 ARVO-Champalimaud Foundation Ocular Oncogenesis and Oncology Conference.